Etiqueta de registo: 00000nam 2200025 450
001 2112219
003 http://id.bnportugal.gov.pt/bib/catbnp/2112219
100 ## $a20221012d2022 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $aa m 000yy
106 ## $ar
200 1# $aPatient safety$ecardio and cerebrovascular risk of major adverse events following exposure to potentially inappropriate medications$fJoão Pedro Teixeira Aguiar$gorient. Filipa Alves Costa, Ana Paula Martins, Hubert G. M. Leufkens
210 #9 $aLisboa$c[s.n.],$d2022
215 ## $aXXVIII, 211, [10] p.$cil.$d30 cm
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Fac. de Farmácia, Univ. de Lisboa, 2022
675 ## $a615(043)$vBN$zpor$31318077
700 #1 $aAguiar,$bJoão Pedro Teixeira$31861021
702 #1 $aCosta,$bFilipa Alves$4727$31861022
702 #1 $aLeufkens,$bHubert G. M.$4727$31733408
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
801 #0 $aPT$bBN$gRPC
856 40 $2Cópia digital disponível no Repositório Universidade de Lisboa$uhttp://hdl.handle.net/10451/54885
966 ## $lBN$mFGMON$sS.A. 183539 V.$x1
971 ## $ccsilva$d20221012
972 ## $e0$z0$d20230220$viquintas
973 ## $cmlsousa$d20230216

Etiqueta de registo: 00000nam 2200025 450
001 2005034
003 http://id.bnportugal.gov.pt/bib/catbnp/2005034
100 ## $a20181112d2018 k y0pory01030103ba
101 0# $aeng$dpor
102 ## $aPT
105 ## $ay m 000yy
106 ## $ar
200 1# $aIntensive monitoring in Portugal$e a pharmacy-based model to assess medicines in real-life conditions$e the example of new glucose lowering drugs$fCarla de Matos Torre$gorient. Ana Paula Martins, Hubert G. M. Leufkens
210 #9 $aLisboa$c[s.n.],$d2018
215 ## $a278 p.$d30 cm$ecurriculum vitae (8 p.)
328 #1 $aTese dout. Farmácia (Farmacoepidemiologia), Faculdade de Farmácia, Univ. Lisboa, 2018
675 ## $a615.015(469)(043)$vBN$zpor$31317391
675 ## $a616.379-008.6(043)$vBN$zpor$31225752
700 #1 $aTorres,$bCarla de Matos$31733407
702 #1 $aMartins,$bAna Paula$f1965-$4727$31251573
702 #1 $aLeufkens,$bHubert G. M.$4727$31733408
801 #0 $aPT$bBN$gRPC
966 ## $lBN$mFGMON$sS.A. 170357 V.$x1